Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
93 Cards in this Set
- Front
- Back
Osmosis
|
Fluid shifts (movement of water) between comparments (plasma vs. interstitial vs. cell)
|
|
Osmolarity
|
Measurement of how concentrated a comparment is
|
|
High Concentration
|
More solutes, less water
|
|
Low Concentration
|
Less solutes, more water
|
|
Tonicity/Salinity
|
Saltiness of a fluid
|
|
Normal Tonicity of blood is _____
|
0.9% saline concentration (NaCl); isotonic
|
|
Hypertonic/Hyperosmolar
|
Saline concentration higher than 0.9%; blood is more concentrated
|
|
Hypotonic/Hypoosmolar
|
Saline concentration is lower than 0.9%; blood is less concentrated
|
|
Osmotic Pressure
|
Pressure exerted by all the solutes in a compartment
|
|
Higher osmolarity, _____ osmotic pressure
|
Higher
|
|
Oncotic Pressure
|
Same principle as osmotic pressure, but specifically to protein molecules
|
|
Rule of Osmosis
|
Water will always want to move from a more dilute compartment to a more concentrated compartment
|
|
Two Fluid Balance Changes
|
Water lost = Increased concentration of plasma space (blood); tissue to blood shift
Water gained/protein lost = decreased concentration of plasma space (blood); blood to tissue shift |
|
Skin Turgor
|
State of flexibility or tightness of the skin cells due to how much water they have
|
|
Oliguria
|
Diminished urinary output
|
|
S&S Dehydration of Brain Cells
|
Restlessness, confusion, unconsciousness, convulsions
|
|
High serum osmolarity = (hyper/hypo)osmolar
|
Hyperosmolar
|
|
Intrinsic Hormonal Compensatory mechanism to correct fluid volume deficit and/or low blood pressure
|
RAAS: Renin-Angiotensin-Aldosterone System
|
|
Explain RAAS
|
Increased Renin secreted, stimulates secretion of Angiotensin I which becomes Angiotensin II with the help of ACE (angiotensin converting enzyme)
|
|
Increased Renin is secreted when:
|
Blood osmolarity is high, fluid volume in circulation is low, blood pressure is low
|
|
Angtiotensin II Duties
|
Stimulate peripheral vasoconstriction and increase secretion of aldosterone
|
|
Peripheral Vasoconstriction
|
Less blood will flow into constricted blood vessels; blood stays within central circulation
|
|
Aldosterone
|
Kidney tubules retain sodium (Na+), water follows the sodium (Na+) back into circulation, decreasing urine output, increase in circulatory volume
|
|
RAAS is suppressed when:
|
Fluid volume is high
|
|
ADH
|
Antidiuretic Hormone; assists RAAS secretion
|
|
Water gain/protein loss results in:
|
Decreased blood osmolarity
|
|
Excess water causes _______ of blood.
|
Dilution; lower serum osmolarity
|
|
Edema
|
Excess fluid being pulled into the tissue
Imparis body processes: healing and oxygen exchange |
|
During kidney failure, water ________
|
Accumulates
|
|
SIADH
|
Syndrome of Inappropriate (Increased) Antidiuretic Hormone
|
|
Abnormally high levels of ADH:
|
Decreased urination ("holding onto" water) increases vascular fluid volume; Water has been added to the blood which dilutes the plasma compartment
|
|
Solutes most affected by fluid shift:
|
Sodium (Na+)
Proteins |
|
Hypoproteinemia
|
Protein loss in the blood
|
|
Causes of Hypoproteinemia
|
Diminished protein production, diminished protein intake, and plasma protein loss
|
|
Sequelae of Hypoproteinemia
|
Less solutes in blood, lower concentration in plasma compartment, and lower concentration that neighboring tissue; Vascular space is hypoosmolar and has low oncotic pressure
|
|
Blood to Tissue Fluid Shift state
|
Fluid volume overload or excess
|
|
Fluid volume excess/overload labs and pt's blood characteristics
|
Low serum osmolarity; pt's. blood would be hypoosmolar, hypotonic, low oncotic pressure, and low osmotic pressure
|
|
Correcting fluid volume excess/overload hormone
|
Natriuretic Peptide System (NPS)
|
|
Natiruretic Peptide System (NPS)
|
Increases urination (diuresis)
|
|
Apoptosis
|
Normal cell death; programmed death; cell suicide
|
|
Necrosis
|
Abnormal cell death; occurs from irreversible cell injury
|
|
Inflammation
|
Commonality of all injury to cells/tissue
One of the first steps to healing |
|
In the case of bad cell swelling and leaking
|
Water is coming in, intracellular substances are leaking out into immediate surrounding tissue and finds way into capillaries, and thus into blood stream
|
|
Serum lab measurements of intracellular proteins (diagnostic/prognostic)
|
Higher serum measurement, worse damage
|
|
Creatine Kinase
|
Catalyze transference of phosphate groups back and forth between ADP and ATP
|
|
Myoglobin
|
Muscle protein
|
|
Troponin
|
Protein molecule only found in heart muscle
|
|
Ischemia
|
Oxygen deprivation to cells (hypoxia) due to a decrease in arterial circulation to a specific area
|
|
Mechansim of ischemia
|
Narrow and/or blocked arteries; chronic or acute
|
|
Acute ischemia examples
|
Arterial embolus
Sickle Cell Crisis |
|
Arterial Embolus
|
Clot travels in arteries until it is lodged in small blood vessel
|
|
Sickle Cell Crisis
|
Abnormally shaped RBCs get stuck in capillaries
|
|
Chronic ischemia examples
|
Atherosclerosis
Thrombus |
|
Atherosclerosis
|
Gradual narrowing of arteries
|
|
Thrombus
|
Slow-developing clot
|
|
Infarction
|
Untreated acute/chronic ischemic situation; Necrosis from lack of arterial blood supply to specific area
|
|
Carbon Monoxide mechanism
|
Carbon monoxide (CO) has a high affinity for hemoglobin (Hgb); CO binds to Hgb, forms Carbodyhemoglobin (HgCO) which prevents oxygen from binding to Hgb
|
|
Abnormal Cellular Accumulations: Gout
|
Systemic disease caused by a build up of uric acid in the blood (hyperuricemia)
|
|
Uric Acid
|
Breakdown product of purine (organic compound); normally excess uric acid is excreted in urine
|
|
Free Radicals
|
Separate molecular "species", do not behave like normal atoms and molecules; "spin-off" of abnormal, accelerated, and/or uncontrolled reactions
|
|
Adaptation
|
Process of accommodating to a new situation the body is undergoing, or creating a new state to accommodate changes in environment/situation; temporary or permanent
|
|
Normal adaptation is __________.
|
Physiologic
|
|
Abnormal adaptation is __________.
|
Pathologic
|
|
Atrophy
|
Decrease/shrinkage in cellular size
|
|
Hypertrophy
|
Increase in cellular size (consequently, organ increases in size too); accumulation of cellular proteins, NOT cellular fluid
|
|
Hypertrophy is cause by ___________.
|
Hormonal situation of increased functional demand
|
|
Hyperplasia
|
Increase in number of cells resulting from increased rate of cell division
|
|
Metaplasia
|
Reversible replacement of one mature cell by another type of mature cell; happens when cells are subjected to chronic injury or irritation
|
|
Dysplasia
|
Abnormal changes in size, shape, and organization of mature cells due to persistent, severe cell injury/irritation
|
|
Cell Proliferation
|
Multiplication or reproduction of cells; rapid expansion of cell population
|
|
An altered cell proliferation disease process includes _______.
|
Cancer
|
|
Tumor/Neoplasm
|
Abnormal mass of tissue
|
|
Benign Tumor Characteristics
|
Slower growth rate, well-encapsulated, non-metastasizing, well-differentiated, closely resemble tissue they arose from
|
|
Malignant Tumor Characteristics
|
Very rapid growth rate, poor differentiated, metastasis can occur (not well-encapsulated)
|
|
Metastasis
|
Invasion of sites distant to immediate area
|
|
Oncology
|
Study/Field of cancer
|
|
Cancer Etiology
|
Gene mutations (prompted by many factors)
|
|
Oncogene
|
Genetic mutation that sets cancer into motion
|
|
Clonal Proliferation
|
Promoted by the oncogene, rapid increase in growth and development
|
|
Clonal proliferation occurs by ______.
|
Cells overreacting to growth factor signals (wild, rapid duplication with no differentiation), overriding normal "braking" signals, stimulating development of tumor's own blood supply (cancer cells divert nourishment from other cells)
|
|
Anaplasia
|
Loss of differentiation
|
|
Angiogenesis
|
Development of new blood vessels
|
|
Tumor Markers
|
Substances produced in the body by cancer cells or released by cancer-damaged tissue that can be found in blood, spina fluid, or urine
|
|
Genetic Markers
|
Genetic abnormalities that are found in some peoople that predict the odds of having certain types of cancer
|
|
Staging of a Tumor
|
How far along the growth is
|
|
Staging Measurements: T, N, M
|
T = Size of tumor
N = Extent of lymph node involvement M = Metastasis |
|
Metastasis
|
Spreading of cancerous cells to other tissues beyond the local lymph nodes
|
|
Classification of Tumors
|
Benign and Malignant
|
|
Benign Tumors: Naming
|
First part of name = Tissue involved
Ends with "oma" |
|
Malignant Tumors: Naming
|
First part of name = Cell type of origin and
Root word of "carcino", "sarco", or "blasto" Ends with "oma" |
|
Carcinoma
|
Epithelial tissue
|
|
Sarcoma
|
Connective tissue
|
|
Blastoma
|
Neural tissue
|